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Investigation on the biochemical isomerization of
ibuprofen led us to the successful purification of “2arylpropionyl-CoA epimerase* from rat liver cytosol
and mitochondria. The purified enzymes from both
subcellular fractions exhibit similar physical and catalytic properties and are distinctly different from rat
liver methylmalonyl-CoA epimerase. Both are monomeric proteins with an apparent molecular mass of 42
kDa and show similar contents of most amino acids.
Their UV spectra gave no indication of any bound
cofactors, and their enzyme activities werenot affected
by exposure to EDTAor metal ions (except Cu2+).These
results suggest that the cytosolic and mitochondrial
epimerases may be structurally related. The purified
enzymes catalyze the epimerization of various 2-arylpropionyl-CoAs with some degree of stereochemical
differentiation. For 2-(4-isobutylphenyl)propionylCoA, the equilibrium constant was estimated to be 1.5
in favor of the R-isomer. Evidence indicated that the
proton exchange may be mediated by a 2-base mechanism and that a carboxylic residue in the active site
may serve asa general base for proton abstraction.

The 2-arylpropionic acids are an important group of nonsteroidalantiinflammatory drugs, commonly used for the
treatment of pain, fever, and inflammation, as well as other
connective tissue and rheumatologic diseases. Their activity
in inhibiting prostaglandin synthesis is mainly contributed
by the S-enantiomers. Withthe exception of naproxen, these
therapeutic agents, such as ibuprofen and fenoprofen, are
administered asracemic mixtures. A unique feature regarding
2-arylpropionic acid metabolism is the stereoselective conversion of the R-enantiomer to its S-counterpart, but not vice
versa (1).Such unidirectional inversion has been documented
in many species of mammals, including humans (2, 3). This
biochemical transformation leads to elevated serum levels of
the active species and in essence accounts for a bioactivation
process. Although this metabolic inversion may not represent
a potential pitfall for healthy individuals, it is of concern to
those with asymptomatic kidney or liver dysfunction due to
the suppression of renal prostaglandin synthesis (4-6).Incidences of acute kidney failure have been reported in metabolically compromised patients after short-termuse of ibuprofen
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FIG. 1. Mechanism of metabolic stereoisomeric inversion of
2-arylpropionic acids.

A generally accepted biochemical pathway for this metabolic event is shown in Fig. l (9). The step of acyl-CoA
formation has been shown to play a pivotal role in controlling
the overall stereoselectivity, with only the R-enantiomer converted to its CoA-thioester (10, 11).
A putative enzyme, “2-arylpropionyl-CoAepimerase,”’ subsequently mediates a rapid interconversion between the Rand S-epimers which, upon the action of a thioesterase, yield
the free acids. Previously, using rat liver and kidney homogenates, we presented evidence indicating that the epimerization of 2-(4-isobutylphenyl)propionic acid (ibuprofen) proceeds via this CoA-dependent proton abstraction mechanism
(3, 12). Yet, the identity and biological function of this putative epimerase remain to be explored. In thispaper, we report
the purification and characterization of 2-arylpropionyl-CoA
epimerases from two subcellular fractions, cytosol and mitochondria, of rat liver.
EXPERIMENTALPROCEDURES

Materials

Racemic 2-(4-isobutylphenyl)propionic acid (ibuprofen) was prepared from commercial ibuprofen tablets andpurified by recrystallization from petroleumether. Racemic [2-2H]2-(4-isobutylphenyl)propionic acid was synthesized via the deuterium exchange of the
a-proton withexcess amounts of CH,OD in the presenceof CH,ONa
(13). Optically active 2-(4-isobutylphenyl)propionic acid and its deuterated derivatives were prepared by the enzymatic resolution of the
corresponding racemic methyl esters (13). The CoA thioesters were
synthesized via the mixed anhydride method asdescribed previously
(3). The diastereomericexcess ( d . e . )of chemically synthesized 2-(4isobutylpheny1)propionyLCoA was greater than 95%. Calculation of
(7, 8).
the diastereomericcomposition was based on the equation,d.e. = ( A
* This work was supported by Grant GM-39236 from the National - B ) / ( A + B ) , where A and B are the concentrations of the major
Institutes of Health. The costs of publication of this article were and minor isomers, respectively. All chromatographic materials, exdefrayed in part by the payment of page charges. This article must cept hydroxylapatite, were purchased from Sigma. Hydroxylapatite
therefore be hereby marked “aduertisement” in accordance with 18 gel was obtained from SpectrumMedical Industries, Inc. Other chemU.S.C. Section 1734 solely to indicate this fact.
$ T o whom correspondence and reprint requests should
be ad’ As the natural function of this epimerase remains unknown, the
dressed. Tel.: 401-792-5048; Fax: 401-792-2181.
nomenclature is tentative.
~

3487

3488

Novel 2-Arylpropionyl-CoA Epimerases from Rat Liver

icals and biochemicals were supplied from Sigma or Aldrich unless
otherwise mentioned.
Subcellular Fractionation
An adult male Charles River Wistar rat, weighing 250-300 g, was
sacrificed by decapitation after light ether anesthesia. The liver was
removed, minced, suspended in 2 volumes of ice-cold 100 mM potassium phosphate buffer, pH 7.0, containing 1 mM a-toluenesulfonyl
fluoride, 1 mM EDTA, 0.25 M sucrose (Buffer A), and homogenized
in a mechanically driven Teflon glass homogenizer (five vertical
passes at low speed). The liver homogenate was centrifuged for 10
min at 3,500 X g to prepare postnuclear supernatant. The mitochondrial and lysosomal fractions were prepared from postnuclear supernatant by density gradient methods (14). The postnuclear supernatant was centrifuged at 10,000 X g for 10 min, and the resulting
supernatant was further centrifuged at 100,000 X g for 1 h to yield
the microsomal and cytosolic soluble fractions. All fractions were
treated with Triton X-100 at a final concentration of 0.1% (w/v)
before assay. The activities of the marker enzymes (lactate dehydrogenase, cytochrome c oxidase, and @-galactosidase)were analyzed
according to theprocedures described by Storrie and Madden (14).
2-Arylpropionyl-CoAEpimerase Assay
Activities of the 2-arylpropionyl-CoA epimerase in all the enzyme
preparations were assayed using an enantioselective HPLC' method
as described previously (3) with slight modifications. The incubation
mixture contained 100 mM potassium phosphate buffer, pH 7.0, 1
mM EDTA (buffer B), a suitable amount of the enzyme, and 0.5 mM
( S ) -or (R)-2-(4-isobutylphenyl)propionyl-CoA
in a final volume of 1
ml. The enzyme reaction was started by the addition of substrate.
After gentle shaking at 30 "C for 5 min, the reaction was terminated
by adding 0.3 ml of 2.5 M hydroxylamine solution, pH 7.0. Extraction
of the resulting hydroxamic acid with ether, followed by 6 N HCl
hydrolysis, afforded free 2-(4-isobutylphenyl)propionicacid. The acid
was then converted to theacyl chloride and then to thecorresponding
(lR,PS,5R)-menthyl ester. The diastereomeric composition was determined by HPLC. A control assay without enzyme addition was
conducted simultaneously to determine the background value, which
was subtracted. No background epimerization could be detected under
these assay conditions. Enzyme activity was expressed as @molesof
(R)-2-(4-isobutylphenyl)propionyl-CoA
formed from the S-substrate
per min at 30 "C.
Purification of 2-Arylpropionyl-CoAEpimerase from Rat Liver
Cytosol and Mitochondria

All operations were performed at 4 "C unless otherwise stated. The
postnuclear supernatant was centrifuged at 10,000 x g for 10 min.
The supernatant, after further centrifugation at 100,000 X g for 1 h,
served as the source for the purification of the cytosolic epimerase.
The 10,000 X g pellets that contained mostly mitochondria were
washed with buffer A twice and resuspended in buffer B containing
1 mM a-toluenesulfonyl fluoride (buffer C ) . The mitochondrial fraction was treated with Triton X-100 at a final concentration of 0.125%
and was centrifuged at 30,000 X g for 15 min. The supernatant was
dialyzed against buffer C for 16 h and used for the isolation of the
mitochondrial epimerase. Procedures for the purification of 2-arylpropionyl-CoA epimerases from both fractions were similar except
that gel filtration chromatography was not required for the mitochondrial enzyme.
Ammonium Sulfate Precipitation (Step 1)-Solid ammonium sulfate was added to the supernatant to 35% saturation while the pH
was maintained at 7.0 with 1 N ammonium hydroxide. After being
stirred for 10 min, the preparation was centrifuged at 10,000 X g for
20 min. The supernatant was brought to 65% saturation with solid
ammonium sulfate, stirred for 10 min, and centrifuged as described
ureviouslv. The ureciuitate was resusuended in 20 mM imidazole

enzymes, respectively. The column was washed with the same buffer
until the absorbance at 280 nm returned to thebase line. The adsorbed
protein was eluted with 50 mM NaCl and then with a linear salt
gradient of 50-300 mM NaCl in the same buffer. The active fractions
were pooled, concentrated over a 10,000 cutoff ultrafiltration membrane (Filtron Omega unit) and dialyzed against 15 mM potassium
phosphate, pH 7.0, for 16 h.
Hydroxylapatite Chromatography (Step 3)"The dialyzed sample
from step 2 was applied to the hydroxylapatite column equilibrated
with 15 mM potassium phosphate buffer, pH 7.0. The column sizes
were 2.5 X 13 and 2.5 X 8 cm for the cytosolic and mitochondrial
enzymes, respectively. The adsorbed proteins were eluted with a linear
gradient (15-100 mM) of potassium phosphate buffer, pH 7.0. Fractions exhibiting epimerase activity were collected, concentrated by
ultrafiltration, and dialyzed against 20 mM sodium phosphate buffer,
pH 7.0, containing ammonium sulfate with 12% saturation.
Phenyl-Sepharose CL-4B Chromatography (Step 4)"The dialyzed
sample from step 3 was applied onto a phenyl-Sepharose column
equilibrated with the dialysis buffer. The column sizes for the cytosolic and mitochondrial enzymes were 2.5 X 8 and 2.5 X 7 cm,
respectively. A gradient of 12% saturation of ammonium sulfate to
50% ethylene glycol in 20 mM sodium phosphate, pH 7.0, was used
to elute the adsorbed proteins. The active fractions werepooled,
concentrated, anddialyzed against 10 mM sodium phosphate, pH 6.7,
containing 50 mM NaCl.
Red Dye Affinity Chromatography (Step 5)"The dialyzed solution
from step 4 was loaded onto a Reactive Red 120-agarose (type 3000CL) column equilibrated with the dialysis buffer. The column sizes
were 1.5 X 4 and 1.5 X 3.5cm for the cytosolic and mitochondrial
enzymes, respectively. Elution buffer was a gradient of 50-500 mM
NaCl in 10 mM sodium phosphate, pH 6.7.
Sephacryl S-200 Chromatography (Step 6)"The cytosolic epimerase from step 5 was concentrated to about 10 ml and further purified
by a Sephacryl S-200 column (2.5 X 90 cm). The equilibration and
eluting buffer was 50 mM Tris/HCl, pH 7.5, containing 50 mM NaCI.
Homogeneity and Molecular Mass Determinations
The purity and molecular mass of the purified epimerase were
analyzed by 12% polyacrylamide gels containing 0.1% SDS (SDSpolyacrylamide gel electrophoresis) according to the method described
by Laemmli (15). The molecular mass standards were bovine serum
albumin (66,000 Da), ovalbumin (45,000 Da), glyceraldehyde-3-phosphate dehydrogenase (36,000 Da), carbonic anhydrase (29,000 kDa),
trypsinogen (24,000 Da), trypsin inhibitor (20,100 Da), and a-lactalbumin (14,200 Da). Gels were stained with Coomassie Brilliant Blue
after electrophoresis. The molecular mass was also estimated by gel
filtration chromatography on a sephacryl S-200 column (90 X 2.5 cm)
equilibrated with 50 mM Tris/HCl, pH 7.5, containing 50 mM NaCl.
Blue dextran (2,000,000Da) was used to determine the void volume.
The proteins used as calibration standards were @-amylase(200,000
Da), alcohol dehydrogenase (150,000 Da), bovine serum albumin
(66,000 Da), carbonic anhydrase (29,000 Da),and cytochrome c
(12,400 Da).
Miscellaneous
Protein determinations were performed using a Coomassie Blue
dye-binding method (16) using a commercial reagent (Pierce Chemical Co.) with bovine serum albumin as a standard. Protein concentrations during purification were determined by measuring the absorbance at 280 nm. The amino acid analyses were independently
performed by the Protein/Nucleic Acid Shared Facility at the Medical
College of Wisconsin and by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University. The results from
both facilities were consistent. Low resolution electron impact and
chemical ionization mass spectra were obtained on a Kratos MS80RFA spectrometer, Chemical Instrument Center, Yale University.
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method with (S)-2-(4-isobutylphenyl)propionyl-CoA
as substrate. As indicated by the relative specific activities of the
marker enzymes (Table I), each subcellular fraction was enriched after differential centrifugation. Although mitochondria and lysosome could not be completely separated by the
metrizamide method (20), the epimerase activity in lysosome
was negligible. The enzyme activity was located predominantly in the cytosol (51%) and mitochondria (30%), and to
a lesser extent, in the microsomes (16%). It is interesting to
note that intact mitochondria prior to detergent treatment
also mediated the epimerization reaction at rates comparable
with those of Triton X-100-treated mitochondria.
Purification of 2-Arylpropionyl-CoA Epimerase from Mitochondria and Cytosol-Enzyme purification from the cytosolic
and mitochondrial fractions was similar except that the cytosolic enzyme required an additional step, Sephacryl S-200
column chromatography, to achieve homogeneity (Table 11).
The overall procedures resulted in a 3,500-fold purification
for the cytosolic epimerase and a 1,600-fold purification for
the mitochondrial enzyme. The low increases in specific activity during the initial stepsmight be caused by the interference of thioesterase(s)during the assays. With(S)-2-(4isobutylpheny1)propionyl-CoAas substrate, the specific activities were 410 and 600 pmol/min/mg protein for the cytosolic and mitochondria enzymes, respectively.
Purity and Molecular Mass-The degree of purity of both
enzyme preparations was assessed by SDS-polyacrylamide gel
electrophoresis (Fig. 2). Both enzyme preparations gave a
single protein band with a molecular mass of 42,000 Da. The
native molecular masses of these two enzymes were estimated
t o be 40,000 Da by gelfiltration on Sephacryl S-200 (data not
shown), indicating that both epimerases are monomeric proteins.
Enzyme Properties-The purified enzyme, from either cytosol or mitochondria, became inactivated after freezing and
thawing. Thus, the enzyme preparations were stored at 4 "C
in 10 mM potassium phosphate buffer containing 5%ethylene
glycol and 0.02% NaN3. Heat treatments resulted in irreversible inactivation of the enzyme. At 50 "C, tllz for inactivation
was about 5 min. When the enzyme was treated at 80 "C for
the same period of time, complete loss of activity was noted,
Optimal pHwas studied in the pHrange of 4.5-9.5. Epimerase
activity rose sharply between pH 4.5 and 5.0 and reached a
plateau from pH 5.5 through pH 9.5. (Fig. 3). Study at pH
higher than 9.5was prohibited for two reasons. First, the
thioester bond hydrolyzes spontaneously at pHvalues greater
than 10; second, as the pK, of the a-methine proton is about
10.3 (12), chemical epimerization becomes significant at such
a high pH.
Amino Acid Composition-The amino acid compositions of
both epimerase preparations are shown in Table 111. Both

enzymes are rich in Glx, Gly, and Leu but low in Cys, Met,
Tyr, His, and Trp contents. The (Glx Asx)/(Lys + Arg)
ratiosare 2.0 and 2.1 for the cytosolic and mitochondrial
enzymes, respectively, indicating the acidic nature of the
proteins. This is consistent with the PI value of the cytosolic
epimerase, whichwas determined to be 5.5by isoelectric
focusing electrophoresis.
Cofactor Requirements-Our study indicated that no exogenous cofactor is required for the epimerase activity. The
spectra of these two enzyme preparations showed no absorption other than that attributable to the protein. Addition of
NAD(P)+, FAD, or FMN did not increase the activity. No
change in activity occurred upon treatment with EDTA (0.5
mM) or various metal ions (0.5 mM) including Ni2+, M e ,
Co2+,Fe3', Fez+,Mn2+,and Zn2+. However,preincubation of
cytosolic or mitochondrial 2-arylpropionyl-CoA epimerase
with 0.5 mM Cu2+in 100 mM potassium phosphate buffer, pH
7.0, at 30 "C for 10 min resulted in 65 and 70% loss of the
activity, respectively.
Substrate Specificity and Approach Equilibrium StudyThe purified epimerase, either of cytosolic or mitochondrial
origin, catalyzed the epimerization of both ( S ) -and (R)-2-(4isobutylpheny1)propionyl-CoA.No racemization could be detected with the corresponding free acids as substrate. Using
the mitochondrial enzyme, the apparent initial rates of epimerization were 1,120and 3,180 pmol/min/mg protein for the
( R ) - and (S)-2-(4-isobutylphenyl)propionyl-CoA,respectively. The reactions reached an equilibrium in favor of the
(R)-isomer from either directions (Fig. 4). The diastereomeric
excess of the product was calculated to be 0.2, which is
consistent with the value determined previously using crude
liver homogenates (3). Accordingly, the equilibrium constant
(I&) is estimated to be 1.5.
Besides the above CoA thioesters, 2-arylpropionyl-CoAepiand ( S ) merase can also utilizes (S)-2-phenylpropionyl-CoA
2-(6-methoxynaphthyl)propionyl-CoA
at rates comparable to
that of (S)-2-(4-isobutylphenyl)propionyl-CoA.
a-Proton Exchange-To assess the mechanism of proton
exchange in the catalytic site, (R)-2-[2-ZH]-(4-Isobutylpheny1)propionyl-CoA was used as substrate for cytosolic 2arylpropionyl-CoA epimerase. After 20% conversion, the reaction was terminated by hydroxylamine at pH 7.0. The ( R ) and (S)-isomers were separated as diastereomeric menthyl
esters by HPLC andanalyzed by mass spectrometry. Virtually
no deuterium was found attached to the S-epimer product,
indicating that the hydrogen atom of the new C-H bond is
derived from the solvent protons.

+

DISCUSSION

The enzyme responsible for the epimerization of 2-arylpropionyl-CoA was purified to homogeneity from rat liver cytosol

TABLEI
Subcellular distribution of marker enzymes and 2-arylpropionyl-CoA epimerase activity in
the rat liver
Relative specific activities of marker enzymes
Subcellular fraction

Postnuclear supernatant
Cytosol
Mitochondria
Lysosome
Microsomes

Lactate
dehydrogenase

Cytochrome e
oxidase

0-Galactosidase

2-Arylpropionyl-CoAepimerase
Total activitg

Distribution

units

%

1
1
615
0.17
0.13
454
51
6.0
30
2.6
265
1.5
13.3
31
3
0.80
16
0.58
144
Total activity was measured fromeach subcellular fraction isolated from rat liverpostnuclear supernatant containing 1430 mg of protein.
1
1.71
0.16
0
0.19
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TABLE
I1
Purification of 2-arylpropionyl-CoA epimerases f r o m rat liver cytosol and mitochondria
Cytosolic epimerase

mg

units

Crude homogenate
0.12
1,366
11,420
Ammonium sulfate (35-65%)
2,844
DEAE-Sepharose
358
6
Hydroxylapatite
3.6 70
Phenyl-Sepharose
36
175
4.8
dye
0.036
Red
1,700
200
52
0.26
3,500Sephacryl410
S-200
46
0.11

1

2

3

Mitochondrial epimerase

units/mg

-/Old

1

5121.5
261
252

0.18
0.73
30
300

35

KDa
1.00

-

0.80

-

0.60

-

-66

- 45
- 36

- 29
- 24
- 20.1
- 14.2
FIG. 2. SDS-polyacrylamide gel electrophoresis of purified
2-arylpropionyl-CoA epimerase. The proteins were analyzed on
a 12% gel. Lane I, the mitochondrial epimerase; lane 2, the cytosolic
epimerase; lane 3, molecular mass standards.

and mitochondria with high purification folds. This purification represents the first preparation of such a n epimerase in
highly purifiedform. Several lines of physical and mechanistic
evidence indicate that this 2-arylpropionyl-CoA epimerase is
distinctivelydifferentfrommethylmalonyl-CoA
epimerase
(21) (Table IV) and many other known epimerases reported
in the ratliver. However, a t present, one cannotexclude that
the epimerase is a known protein with multiple enzymatic
functions. To investigate this possibility, elucidation of the
protein sequence is currently in progress.
It is interesting to note that the epimerase activity
is located
in both cytosol and mitochondria. The purified proteins from
both fractions exhibit similar physical and catalytic properties. Their chromatographic behaviors were nearly identical
throughout the purification. Both are monomeric proteins
with an apparent molecular mass of 42,000 Da. Their UV
spectra gave no indication of bound pyridine orflavin nucleosides, and the enzyme activity was not affected by exposure
t o EDTA or metalions except Cu2+. Amino acid
compositions
indicated that both epimerases had similar contentsin most
of the amino acidsexcept Ser, Gly, and Leu. Attempts to
determine the N-terminal sequences of these two proteins

3
'5
'a

w

w
428
96
60
18
13
5.4

units

4.3

unitslny

160
1193.3
96
98
70
11

0.37
1.24
1.6
5.4
600

-fold
1

14
1,600

' 3

2
0.40-

pH

FIG. 3. Effect of pH on 2-arylpropionyl-CoA epimerase. The
activities of the purified cytosolic epimerase were determined after 8min preincubations at 30 "Cwith the following buffers: 0.1 M citrate
buffer at pH 4.5-6.0;0.1 M potassium phosphate buffer at pH 6.5,
7.0, and 7.5; 0.1 M Tris buffer at pH 8.0 and 8.5; 0.1 M glycine buffer
at pH 9.0 and 9.5. No appreciable nonenzymatic epimerization was
detected at these pH values.

TABLE
111
Amino acid compositions of 2-arylpropionyl-CoA epimerases from rat
liver cvtosol and mitochondria
Amino acid

Cysteine/cystine
Aspartic acid/asparagine
Threonine
Serine
Glutamic acid/glutamine
Proline
Glycine
Alanine
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Histidine
Lysine
Tryptophan
Arginine

Cytosolic
epimerase

1.7
8.4
3.9
5.7
12.0
4.2
11.1
8.9
5.2
1.9
3.4
12.8
2.7
4.6
2.7
5.6
0.7
4.7

Mitochondrial
epimerase
mol%

1.6
7.7
4.3
7.6
10.9
5.1
14.7
8.6
5.5
2.1
3.4
10.3
2.2
4.1
2.3
4.6
0.8
4.3

were unsuccessful, presumably due to the posttranslational
blockage at theN termini. These resultsclearly suggest that
the cytosolic and mitochondrial epimerases are structurally
related. It is well understoodthatalthoughmitochondria
contain their own genetic information, most mitochondrial
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discrepancy in the amino acid compositions. To clarify this
speculation, the protein sequences of both enzymes are currently being examined.
It is worth noting that mitochondria with an intact membrane structure can mediate the epimerization reaction. As
acyl-CoA thioesters can readily penetrate the outer membrane
but not the inner membrane of mitochondria (23), we speculate that the epimerase may reside in the intermembrane
space.
The epimerization of 2-(4-isobutylphenyl)propionyl-CoAis
freely reversible from both directions. Some degree of stereochemical discrimination was observed in the substrate utilization and product formation of the epimerase reaction. As
shown in the approach equilibrium study (Fig. 4), the Sisomer is preferentially epimerized by the enzyme. apThe
- . - rate
initial
parent
for (R)-2-(4-isobutvl~henvl)~ro~ionvl-CoA
relative to that of the S-antipode was 35%. Based on the
Haldane relationship (241, (Keq= (k~.t/K,)(S)/(k~at/Km)(R)=
[ R ] / [ S ] )this
, result is consistent with the finding that the
diastereomeric composition at equilibrium lies favoring the
R-isomer ( d e . = 0.2). Accordingly, the equilibrium constant
(I&) was estimated to be 1.5. For many chemically symmetrical reactions mediated by racemases, the equilibrium constants are found to be unity (25).However, it should be noted
that for the epimerization between two diastereomers, this
rule may not hold.
In general, epimerase- or racemase-catalyzed proton exchange can be accounted for by either single-base or 2-base
acceptor mechanism (26). Our experiments indicate that partial enzymatic epimerization of (R)-[2-2H]-2-(4-isobutylpheny1)propionyl-CoA gave the S-product completely depleted of the a-deuterium. This result provides supporting
evidence for the 2-base mechanism. Moreover, the pHprofile
study shows a sharp rise in activity about pH 5.0 followed by
a pH-independent plateau running from pH 5.5 to 9.5, suggesting that a carboxylic residue (Asp or Glu) may serve as a
general base in the active site for proton abstraction. Currently, the nature of the amino acid residues involvedin
proton transfer is being investigated by the chemical modification of the active site. Because metal ions are not required
for the catalysis, the unstable carbanion may be stabilized as
the aci tautomer with an extended conjugated system (26). It
appears that thereprotonation takes place in favor of the Siface of the aci thioester, resulting in the formation of the
product enriched in the R-isomer (Fig. 5). This enantiofacial
differentiation may be attributed to thesteric and/or stereoelectronic effects imposed by the CoA moiety of the molecule.
In conclusion, the significance of 2-arylpropionyl-CoAepimerase is 2-fold. First, this epimerase-mediated reaction represents a novel biocatalysis with unknown biological functions. Understandingof the molecular and mechanistic details
of this new enzyme system may broaden our knowledge inthe
area of biochemical isomerization. Second, it plays a crucial
role in the metabolic bioactivation of 2-arylpropionic acid
nonsteroidal antiinflammatory drugs. The kinetic behavior of
this epimerase may directly contribute to thetoxicity of some
members of these therapeutic agents and warrants attention.
At present, the structural and kinetic properties of these
epimerases are being actively investigated.
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FIG. 4. Approach equilibrium profile. Curves A and E represent time-dependent enzymatic inversion of ( R ) - or (S)-2-(4-isobutylpheny1)propionyl-CoA, respectively. The reaction mixture contained 0.5 mM substrate, 1 pg of purified mitochondrial epimerase,
and 100 mM potassium phosphate, pH 7.0, in a final volume of 12 ml.
At various intervals, 1-ml aliquots were withdrawn and added to tubes
containing 0.3 ml of 0.25 M hydroxylamine, pH 7.0. The enantiomeric
composition of the resulting product was determined according to the
method described under “Experimental Procedures.”
TABLEIV
Enzymatic propertiesof 2-arylpropionyl-CoA epimerase versus
methylmalonyl-CoA epimerase
Enzyme properties

2-Arylpropionyl-CoA
eoimerase

Methylmalonyl-CoA
eoimerase

Molecular weight
Subunit
structure
Cofactor requirement
Effect of EDTA
pH oDtimum

42,000
Monomeric
None
None
5.5-9.5

32,000
Dimeric
Metal ions (e.g. Co2+)
Inactivation
7.0

ENZ- B

I

Re face

H+

Si face

FIG. 5. Enantiofacial differentiation in proton transfer to
the aci thioester.

proteins are coded for by nuclear genes and synthesized in
the cytosol. The precursor proteins containing targeting sequences are posttranslationally imported into mitochondria
where the targeting sequences are hydrolyzed by a signalassociatedpeptidase (22). Thus, itis possible that thecytosolic
epimerase differs from its mitochondrial counterpart by including a short targeting sequence that may account for the
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APPENDIX1.Chromatogramsof cytosolic 2-arylpropionyl-CoA epimerase purification.
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APPENDIX 2 . Chromatograms of
mitochondrial 2-arylpropionyl-CoA
epimerase purification.
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